Yes, of course. Big Pharma will do what they need
Post# of 148112
You can't keep a drug like leronlimab sidelined for very much longer. It is becoming too noticeable now. The people behind this make Shrkeli look like a choirboy. They are his peers. Shrkeli has been caught but they haven't...yet depending on how well oiled they cover their tracks.
I am very very long CYDY and see great things for the company and share price in the near future.